Phathom Pharmaceuticals Inc (PHAT) Insider Trading
- $27,095,812.94
- $74,311,034.23
- Dec. 19, 2024
- Pharmaceutical Co Ltd Takeda
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Dec. 19, 2024 | COO | 1,118 | $8.00 | Sell | $8,944.00 | |
Dec. 19, 2024 | CFO | 1,291 | $8.00 | Sell | $10,328.00 | |
Dec. 13, 2024 | Director | 12,500 | $7.93 | Buy | $99,125.00 | |
July 15, 2024 | COO | 10,901 | $11.72 | Sell | $127,759.72 | |
July 15, 2024 | Insider | 33,848 | $11.72 | Sell | $396,698.56 | |
July 15, 2024 | CFO | 4,325 | $11.72 | Sell | $50,689.00 | |
April 8, 2024 | CFO | 3,435 | $11.10 | Sell | $38,128.50 | |
March 22, 2024 | Insider | 16,851 | $9.11 | Sell | $153,512.61 | |
Jan. 24, 2024 | Major Shareholder | 3,703,703 | $8.10 | Sell | $29,999,994.30 | |
Jan. 19, 2024 | CFO | 6,307 | $7.75 | Sell | $48,879.25 | |
Nov. 8, 2023 | Director | 2,500 | $7.80 | Buy | $19,500.00 | |
Nov. 6, 2023 | Director | 1,000 | $8.04 | Buy | $8,040.00 | |
Nov. 1, 2023 | CFO | 12,492 | $8.88 | Sell | $110,928.96 | |
June 2, 2023 | CFO | 1,960 | $11.41 | Sell | $22,363.60 | |
May 22, 2023 | CFO | 2,110 | $12.87 | Sell | $27,155.70 | |
April 11, 2023 | COO | 10,000 | $8.26 | Buy | $82,600.00 | |
April 10, 2023 | Director | 1,000 | $7.55 | Buy | $7,550.00 | |
April 6, 2023 | Insider | 12,919 | $7.82 | Buy | $101,026.58 | |
April 6, 2023 | CFO | 3,439 | $7.27 | Sell | $25,001.53 | |
March 1, 2023 | Insider | 1,436 | $8.54 | Sell | $12,263.44 | |
March 1, 2023 | CFO | 2,032 | $8.53 | Sell | $17,332.96 | |
Feb. 13, 2023 | Director | 5,000 | $7.73 | Buy | $38,650.00 | |
Jan. 20, 2023 | Insider | 5,821 | $8.20 | Sell | $47,732.20 | |
Jan. 12, 2023 | Director | 5,000 | $7.00 | Buy | $35,000.00 | |
May 16, 2022 | COO | 20,000 | $8.16 | Buy | $163,200.00 | |
May 13, 2022 | Insider | 20,500 | $7.41 | Buy | $151,905.00 | |
May 12, 2022 | Director | 12,500 | $8.00 | Buy | $100,000.00 | |
March 14, 2022 | Major Shareholder | 18 | $19.00 | Sell | $342.00 | |
Nov. 4, 2021 | Major Shareholder | 1,000,001 | $20.85 | Sell | $20,850,020.85 | |
Oct. 7, 2021 | Director | 15,471 | $32.66 | Sell | $505,282.86 | |
Sept. 21, 2021 | Director | 13,900 | $32.80 | Sell | $455,920.00 | |
Aug. 16, 2021 | Director | 18,000 | $31.25 | Sell | $562,500.00 | |
July 7, 2021 | Major Shareholder | 2,609 | $35.05 | Sell | $91,445.45 | |
July 1, 2021 | Major Shareholder | 8,226 | $35.16 | Sell | $289,226.16 | |
June 28, 2021 | Major Shareholder | 370 | $35.08 | Sell | $12,979.60 | |
June 28, 2021 | Director | 26,040 | $34.07 | Sell | $887,182.80 | |
June 25, 2021 | Major Shareholder | 24,131 | $35.49 | Sell | $856,409.19 | |
June 23, 2021 | Major Shareholder | 200 | $35.00 | Sell | $7,000.00 | |
June 21, 2021 | Major Shareholder | 9,294 | $35.31 | Sell | $328,171.14 | |
June 17, 2021 | Major Shareholder | 3,305 | $35.08 | Sell | $115,939.40 | |
June 14, 2021 | Major Shareholder | 2,826 | $35.06 | Sell | $99,079.56 | |
June 9, 2021 | Major Shareholder | 1,191 | $35.28 | Sell | $42,018.48 | |
June 7, 2021 | Major Shareholder | 2,264 | $35.05 | Sell | $79,353.20 | |
June 1, 2021 | Major Shareholder | 11,211 | $35.78 | Sell | $401,129.58 | |
May 28, 2021 | Major Shareholder | 8,905 | $36.19 | Sell | $322,271.95 | |
May 26, 2021 | Major Shareholder | 12,358 | $36.64 | Sell | $452,797.12 | |
May 26, 2021 | Major Shareholder | 12,358 | $36.64 | Sell | $452,797.12 | |
May 24, 2021 | Major Shareholder | 10,594 | $35.66 | Sell | $377,782.04 | |
May 20, 2021 | Major Shareholder | 7,098 | $35.10 | Sell | $249,139.80 | |
May 19, 2021 | Director | 36,518 | $32.44 | Sell | $1,184,643.92 |
Insiders are both buying and selling Phathom Pharmaceuticals Inc stock.
The insider traders at Phathom Pharmaceuticals Inc are: Pharmaceutical Co Ltd Takeda, David A Socks, Azmi Nabulsi, Molly Henderson, Terrie Curran, Asit Parikh, Ra Capital Management, L.P., Life Sciences Ix L.P. Frazier, and Frank Karbe
The most active insider trader at Phathom Pharmaceuticals Inc is Pharmaceutical Co Ltd Takeda with 24 trades.
Pharmaceutical Co Ltd Takeda has sold the most Phathom Pharmaceuticals Inc stock with a total value of $86,287,992.01.
Life Sciences Ix L.P. Frazier has bought the most Phathom Pharmaceuticals Inc stock with a total value of $49,599,972.72.
The most recent insider trade for Phathom Pharmaceuticals Inc was on Dec. 19, 2024.
The single biggest insider buy for Phathom Pharmaceuticals Inc was from Life Sciences Ix L.P. Frazier with a total value of $24,799,986.36 on Oct. 29, 2019.
The single biggest insider sell for Phathom Pharmaceuticals Inc was from Pharmaceutical Co Ltd Takeda with a total value of $29,999,994.30 on Jan. 24, 2024.